1-(2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropane-1-carbonitrile

Catalog No. :
ACCJUU884
CAS No. :
2227365-42-4
Molecular Formula :
C16H19BFNO2
Molecular Weight :
287.15

IUPAC Name:1-(2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropane-1-carbonitrile

1-(2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropane-1-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$324.00Login to see priceInquiryInquiry
100mg95%$475.00Login to see priceInquiryInquiry
250mg95%$671.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropane-1-carbonitrile
IUPAC Name1-(2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropane-1-carbonitrile
Molecular FormulaC16H19BFNO2
Molecular Weight287.15
SMILESN#CC1(CC1)C2=CC=C(B3OC(C)(C(C)(C)O3)C)C=C2F
InChI KeyKMZYGWAXVCIZFQ-UHFFFAOYSA-N
Synonym1-(2-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarbonitrile;Cyclopropanecarbonitrile, 1-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-
CAS No.2227365-42-4

Synthetic Route by SureRoute

1. ACCJUU884 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCJUU884 route product structure diagram
    ACCJUU8842227365-42-4
Inquiry

2. ACCJUU884 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCJUU884 route product structure diagram
    ACCJUU8842227365-42-4
Inquiry

Comments (0)